Akkaya Taylan, Bedirli Nurdan, Ceylan Tijen, Matkap Erkan, Gulen Guven, Elverici Ozan, Gumus Haluk, Akin Istemihan
Diskapi Training and Research Hospital, I. Anesthesia Clinic, Ankara, Turkey.
Eur J Anaesthesiol. 2009 Apr;26(4):333-7. doi: 10.1097/EJA.0b013e32831c8988.
The aim of this study was to compare the postoperative analgesic efficacy and side-effects of intravenous tramadol with peritonsillar infiltration of tramadol in children undergoing adenotonsillectomy.
Sixty-six children were randomized into two groups: group I received 2 mg kg(-1) tramadol intravenously and group II received 2 mg kg(-1) tramadol in 2 ml of normal saline (1 ml per tonsil) via peritonsillar infiltration. Modified Hannallah pain scale, nausea, vomiting, bleeding, rescue analgesia, sedation and Aldrete scores were recorded at the 1st, 15th, 30th and 60th minute postoperatively. The Aldrete score was used to determine the postanaesthesia care unit discharge criteria. Patients were evaluated for the analgesic requirement, nausea and vomiting, bleeding and sedation.
There were no differences between groups during the first 1 h. In the postanaesthesia care unit, groups I and II had comparable pain scores that were not statistically significant (P > 0.05). But during the first 24 h the additional analgesic requirement of group I (141.81 mg) was more than group II (83.63 mg) (P = 0.002). Pain scores in the postoperative ward at 6, 12 and 24 h were significantly higher in group I than in group II (P < 0.001). Also four patients (12.12%) from group I and one patient (3.05%) from group II had nausea and vomiting in the postanaesthesia care unit and none of the patients had rescue analgesics. There were no differences between groups regarding nausea and vomiting, sedation and bleeding in the postoperative ward.
In adenotonsillectomy cases, peritonsillar infiltration of tramadol maintains efficient pain relief with lower incidence of nausea and vomiting.
本研究旨在比较静脉注射曲马多与扁桃体周围注射曲马多对接受腺样体扁桃体切除术儿童的术后镇痛效果及副作用。
66名儿童被随机分为两组:第一组静脉注射2mg/kg曲马多,第二组通过扁桃体周围注射给予2mg/kg曲马多(溶于2ml生理盐水中,每侧扁桃体注射1ml)。在术后第1、15、30和60分钟记录改良的汉纳拉疼痛量表、恶心、呕吐、出血、补救镇痛、镇静及Aldrete评分。Aldrete评分用于确定麻醉后护理单元出院标准。评估患者的镇痛需求、恶心和呕吐、出血及镇静情况。
前1小时两组之间无差异。在麻醉后护理单元,第一组和第二组的疼痛评分相当,无统计学意义(P>0.05)。但在术后24小时内,第一组的额外镇痛需求量(141.81mg)高于第二组(83.63mg)(P = 0.002)。术后病房6、12和24小时时,第一组的疼痛评分显著高于第二组(P<0.001)。此外,麻醉后护理单元中第一组有4名患者(12.12%)出现恶心和呕吐,第二组有1名患者(3.05%)出现恶心和呕吐,且两组均无患者需要补救镇痛。术后病房中两组在恶心和呕吐、镇静及出血方面无差异。
在腺样体扁桃体切除术中,扁桃体周围注射曲马多能有效缓解疼痛,且恶心和呕吐发生率较低。